BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4896 related articles for article (PubMed ID: 6192770)

  • 1. [Current status of monoclonal antibodies to human melanoma and its application].
    Imai K; Adachi M; Yachi A
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):852-60. PubMed ID: 6192770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical application of monoclonal antibodies to human malignant melanoma-associated antigens].
    Kageshita T; Ishihara K
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1744-8. PubMed ID: 3899015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human monoclonal antibody to tumor-associated ganglioside GD2.
    Katano M; Saxton RE; Irie RF
    J Clin Lab Immunol; 1984 Nov; 15(3):119-26. PubMed ID: 6099419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal hybridoma antibodies in human melanoma: current status.
    Burk MW
    Int Adv Surg Oncol; 1984; 7():241-70. PubMed ID: 6205999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of human melanoma growth in nude mice injected with anti high-molecular-weight melanoma-associated antigen monoclonal antibody 225.28S conjugated to purothionin.
    Matsui M; Nakanishi T; Noguchi T; Imai K; Yachi A; Ferrone S
    Jpn J Cancer Res; 1985 Feb; 76(2):119-23. PubMed ID: 3920101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of monoclonal antibodies to human melanoma-associated antigens.
    Imai K; Ng AK; Ferrone S
    J Natl Cancer Inst; 1981 Mar; 66(3):489-96. PubMed ID: 6162991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of palladium-109-labeled antimelanoma monoclonal antibody for tumor therapy.
    Fawwaz RA; Wang TS; Srivastava SC; Rosen JM; Ferrone S; Hardy MA; Alderson PO
    J Nucl Med; 1984 Jul; 25(7):796-9. PubMed ID: 6737078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells.
    Riemer AB; Hantusch B; Sponer B; Kraml G; Hafner C; Zielinski CC; Scheiner O; Pehamberger H; Jensen-Jarolim E
    Cancer Immunol Immunother; 2005 Jul; 54(7):677-84. PubMed ID: 15565329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated glycolipid antigens defined by monoclonal antibodies.
    Hakomori S
    Bull Cancer; 1983; 70(2):118-26. PubMed ID: 6191806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of monoclonal antibody 155.8 and partial characterization of its proteoglycan antigen on human melanoma cells.
    Harper JR; Bumol TF; Reisfeld RA
    J Immunol; 1984 Apr; 132(4):2096-104. PubMed ID: 6199423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal antitumor antibodies--its application to diagnosis and treatment of tumors].
    Taniguchi M; Wakabayashi S
    Gan No Rinsho; 1983 May; 29(6):654-8. PubMed ID: 6876435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to two determinants of melanoma-antigen p97 act synergistically in complement-dependent cytotoxicity.
    Hellström I; Brown JP; Hellström KE
    J Immunol; 1981 Jul; 127(1):157-60. PubMed ID: 6787119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
    Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
    Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical analysis of a 130,000 molecular weight glycoprotein on human melanoma cells.
    Albino AP; Lloyd KO; Ikeda H; Old LJ
    J Immunol; 1983 Sep; 131(3):1595-9. PubMed ID: 6193195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of tumor-associated antigens in primary and metastatic human malignant melanoma.
    Brüggen J; Bröcker EB; Suter L; Redmann K; Sorg C
    Behring Inst Mitt; 1984 May; (74):19-23. PubMed ID: 6477352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis and shedding of gp87, a human melanoma specific-oncofetal antigen defined by the monoclonal antibody 140.240.
    Liao SK; Khosravi MJ; Kwong PC; Dent PB
    Prog Clin Biol Res; 1983; 133():125-34. PubMed ID: 6622490
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of common acute lymphoblastic leukemia antigen (CALLA) on human malignant melanoma cell lines.
    Carrel S; Schmidt-Kessen A; Mach JP; Heumann D; Girardet C
    J Immunol; 1983 May; 130(5):2456-60. PubMed ID: 6339629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to tumor-associated antigens.
    Zotter S; Grossmann H; Lossnitzer A; Müller M
    Arch Geschwulstforsch; 1984; 54(1):1-12. PubMed ID: 6200086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 245.